Home » Market News » DirectorsTalk Highlights » ImmuPharma PLC are delighted Lanstead Capital has increased its holdings to over 5%
Immupharma Plc

ImmuPharma PLC are delighted Lanstead Capital has increased its holdings to over 5%

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, has received notification that Lanstead Capital LP has confirmed an increase in its holding in ImmuPharma. Lanstead now holds 6,985,893 Ordinary shares of 10p each in the Company, representing 5.01% of ImmuPharma’s issued share capital of 139,467,430 Ordinary shares with voting rights.

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.